Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

40.0%

2 terminated/withdrawn out of 5 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(60.0%)
Phase 1
1(20.0%)
Phase 2
1(20.0%)
5Total
N/A(3)
Phase 1(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05483712Not ApplicableRecruiting

Brass Mesh Bolus in Rotational Post-Mastectomy Radiation Therapy

Role: lead

NCT04176900Not ApplicableWithdrawn

3D Printed Rigid Bolus Versus Silicone Bolus for Treatment of Tumors Involving the Skin: A Comparative Study

Role: lead

NCT03396848Not ApplicableUnknown

Sexual Health and Rehabilitation eClinic (SHAReClinic)

Role: collaborator

NCT01981668Phase 1Withdrawn

The JET Study: a Phase I Trial of Cabazitaxel, Radiotherapy and Long-term Androgen Deprivation

Role: lead

NCT00452556Phase 2Unknown

The ELDORADO (Eligard®, Docetaxel and Radiotherapy) Study

Role: lead

All 5 trials loaded